Reunion

BiotechnologySeries CShanghai, Chinareunionmed.cn

Latest round

Series C

Last raised

Feb 2026

Total raised

$46M

Investors

7

About Reunion

, dba Reunion, operates as an innovative drug developer that focuses on medical hydrogels. More than 80% of Ruining's team has PhD and master's degrees, and the core members were from Fortune 500 companies. The founder and chairman, Zhen Pan, worked as a technical expert for DuPont. The company focuses on the field of medical hydrogel and has independently developed ready-to-use PEG hydrogel materials. It is able to provide clinical medical solutions such as tumor radiotherapy protection, trauma repair, tumor embolization and innovative anti-tumor drugs. Reunion’s revenue is generated primarily from commercial sales of approved medical hydrogel devices, hospital procurement and clinical adoption of innovative medical devices, and strategic collaborations with medical institutions and industry partners.

Who invested in Reunion

7 investors across 5 rounds

See all investors in Reunion

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Feb 28, 2026

    Amount

    $15M

    Investors

    Locked

  2. Series B

    Jan 24, 2024

    Amount

    $14M

    Investors

    Locked

  3. Series A

    Sep 3, 2022

    Amount

    Undisclosed

    Investors

    Locked

  4. Series A

    Jan 4, 2022

    Amount

    $16M

    Investors

    Locked

  5. Seed

    Feb 1, 2021

    Amount

    $1.6M

    Investors

    Locked

Questions about Reunion

Who invested in Reunion?

Reunion has 7 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Reunion raised?

Reunion has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Reunion last raise money?

Reunion's most recent round on record is a Series C, in Feb 2026.

What does Reunion do?

, dba Reunion, operates as an innovative drug developer that focuses on medical hydrogels.

Where is Reunion headquartered?

Reunion is headquartered in Shanghai, China.

Which VCs invest in companies like Reunion?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Reunion's stage. Their profiles are linked below.

Raising like Reunion? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.